siRNA, Anti-Human AKT1, LNA(CAT#: SIRGT04135WQ-LNA)

The product SIRGT04135WQ-LNA is a type of small interfering RNA (siRNA) that targets AKT1 gene and regulates the expression of gene. The siRNA interferes with the expression of AKT1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001014431.1; NM_001014432.1; NM_005163.2
Alternative Names AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA
Related Diseases Proteus Syndrome, Cowden Syndrome
Purification HPLC
Target Gene
Gene ID 207
Uniprot ID P31749

Related Products